Mitrassist

In the United States, 1.6 million patients with life-threatening Mitral Regurgitation (MR) cannot undergo risky open heart surgery to replace or repair the faulty valve. Each year, another 50,000 new patients face the same life-threatening challenge.

See the MitrAssist movie.

	MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. The MitrAssist valve-in-valve —

		treats nearly all MR cases and is safe for patients of all ages,
		preserves the natural mitral valve functionality,
		conforms to any anatomical shape and is designed for long-lasting results, and
		dramatically decreases the length of the procedure and patients’ recovery time.

MitrAssist offers hope to patients in need.